Stealth’s Forzinity: Barth Syndrome Drug’s Uncertain Efficacy Split US FDA

DRP Forzinity main image
The FDA granted accelerated approval to Stealth's Barth syndrome drug Forzinity based on knee extensor muscle strength. (Nancy Pham)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Review Profiles

More from United States